U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Search results

Items: 1 to 100 of 12395

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr17:27274843-30817038
GRCh38:
Chr17:28947825-32490020
ABHD15, ADAP2, ANKRD13B, ATAD5, BLMH, C17orf75, CDK5R1, COPRS, CORO6, CPD, CRLF3, CRYBA1, EFCAB5, EVI2A, EVI2B, GIT1, GOSR1, LOC105371730, LOC106113036, LOC106113037, LOC108281169, LOC108281170, LOC108281180, LOC108281181, LOC108281182, LOC108771181, LOC108771182, LOC108771183, LOC108771184, LOC108783647, LOC108783648, LOC108783652, LOC108783653, LOC110121426, LOC110806262, LOC111811965, LOC112529904, LOC112529905, LOC112529906, LOC112529907, LOC113939959, LOC113939960, LOC121587584, LOC121587585, LOC121587586, LOC125177445, LOC125177446, LOC125177447, LOC125177448, LOC125177449, LOC125177450, LOC125177451, LOC125177452, LOC125177453, LOC125177454, LOC125177455, LOC126862527, LOC126862528, LOC126862529, LOC126862530, LOC126862531, LOC129390847, LOC129390848, LOC129390849, LOC129390850, LOC129390851, LOC129390852, LOC130060584, LOC130060585, LOC130060586, LOC130060587, LOC130060588, LOC130060589, LOC130060590, LOC130060591, LOC130060592, LOC130060593, LOC130060594, LOC130060595, LOC130060596, LOC130060597, LOC130060598, LOC130060599, LOC130060600, LOC130060601, LOC130060602, LOC130060603, LOC130060604, LOC130060605, LOC130060606, LOC130060607, LOC130060608, LOC130060609, LOC130060610, LOC130060611, LOC130060612, LOC130060613, LOC130060614, LOC130060615, LOC130060616, LOC130060617, LOC130060618, LOC130060619, LOC130060620, LOC130060621, LOC130060622, LOC130060623, LOC130060624, LOC130060625, LOC130060626, LOC130060627, LOC130060628, LOC130060629, LOC130060630, LOC130060631, LOC130060632, LOC130060633, LOC130060634, LOC130060635, LOC130060636, LOC130060637, LOC130060638, LOC130060639, LOC130060640, LOC130060641, LOC130060642, LOC130060643, LOC130060644, LOC130060645, LOC130060646, LOC130060647, LOC130060648, LOC130060649, LOC130060650, LOC130060651, LOC130060652, LOC130060653, LOC130060654, LOC130060655, LOC130060656, LOC130060657, LOC130060658, LOC130060659, LOC130060660, LOC130060661, LOC130060662, LOC130060663, LOC130060664, LOC130060665, LOC130060666, LOC130060667, LOC130060668, LOC130060669, LOC130060670, LOC130060671, LOC130060672, LOC130060673, LOC130060674, LOC130060675, LOC130060676, LOC130060677, LOC130060678, LOC130060679, LOC130060680, LOC130060681, LOC130060682, LOC130060683, LRRC37B, MIR193A, MIR3184, MIR365B, MIR365BHG, MIR423, MIR4523, MIR4724, MIR4725, MIR4733, MIR4733HG, MIR632, MYO18A, NF1, NSRP1, NUFIP2, OMG, PHF12, PIPOX, PSMD11, RAB11FIP4, RHBDL3, RHOT1, RNF135, SEZ6, SLC6A4, SSH2, STIN2-VNTR, SUZ12, TAOK1, TBC1D29P, TEFM, TMIGD1, TP53I13, TRT-CGT4-1, UTP6, ZNF207
See casesPathogenic
(Dec 10, 2012)
no assertion criteria provided
2.
GRCh37:
Chr17:28952286-30386515
GRCh38:
Chr17:30625268-32059496
See casesPathogenic
(Aug 26, 2013)
no assertion criteria provided
3.
GRCh37:
Chr17:28957752-30415399
GRCh38:
Chr17:30630734-32088380
See casesPathogenic
(Aug 12, 2011)
criteria provided, single submitter
4.
GRCh38:
Chr17:30660608-31159168
Neurofibromatosis, type 1Pathogenicno assertion criteria provided
5.
GRCh37:
Chr17:28993036-30412788
GRCh38:
Chr17:30666018-32085769
See casesPathogenic
(Aug 1, 2014)
no assertion criteria provided
6.
GRCh37:
Chr17:28994990-30350877
GRCh38:
Chr17:30667972-32023858
See casesPathogenic
(Aug 12, 2011)
criteria provided, single submitter
7.
GRCh37:
Chr17:28999834-30326958
GRCh38:
Chr17:30672816-31999939
See casesPathogenic
(Aug 12, 2011)
criteria provided, single submitter
8.
GRCh37:
Chr17:29004621-30398720
GRCh38:
Chr17:30677603-32071701
See casesUncertain significance
(Feb 14, 2018)
no assertion criteria provided
9.
GRCh37:
Chr17:29005171-30400885
GRCh38:
Chr17:30678153-32073866
See casesPathogenic
(Mar 11, 2013)
no assertion criteria provided
10.
GRCh37:
Chr17:29011937-30348421
GRCh38:
Chr17:30684919-32021402
See casesPathogenic
(Apr 30, 2011)
no assertion criteria provided
11.
GRCh37:
Chr17:29033863-30326952
GRCh38:
Chr17:30706845-31999933
See casesPathogenic
(Sep 21, 2012)
no assertion criteria provided
12.
GRCh37:
Chr17:29033881-30321643
GRCh38:
Chr17:30706863-31994624
See casesPathogenic
(Aug 12, 2011)
criteria provided, single submitter
13.
GRCh37:
Chr17:29033882-30326958
GRCh38:
Chr17:30706864-31999939
See casesPathogenic
(Aug 12, 2011)
criteria provided, single submitter
14.
GRCh37:
Chr17:29033882-30426780
GRCh38:
Chr17:30706864-32099761
See casesPathogenic
(Aug 12, 2011)
criteria provided, single submitter
15.
GRCh37:
Chr17:29033882-30326958
GRCh38:
Chr17:30706864-31999939
See casesUncertain significance
(Feb 14, 2018)
no assertion criteria provided
16.
GRCh37:
Chr17:29094212-30264505
GRCh38:
Chr17:30767194-31937486
See casesPathogenic
(Aug 12, 2011)
criteria provided, single submitter
17.
GRCh37:
Chr17:29158338-29649192
GRCh38:
Chr17:30831320-31322174
See casesUncertain significance
(Mar 10, 2014)
no assertion criteria provided
18.
GRCh37:
Chr17:29421945-29509683
GRCh38:
Chr17:31094927-31182665
LOC108281169, LOC108281170, LOC108281180, LOC111811965, MIR4733HG, NF1Neurofibromatosis, type 1Uncertain significance
(Oct 1, 2016)
criteria provided, single submitter
19.
GRCh37:
Chr17:29421945-29509683
GRCh38:
Chr17:31094927-31182665
LOC108281169, LOC108281170, LOC108281180, LOC111811965, MIR4733HG, NF1Neurofibromatosis, type 1Pathogenic
(Dec 16, 2016)
criteria provided, single submitter
20.
GRCh37:
Chr17:29421945-29422387
GRCh38:
Chr17:31094927-31095369
LOC111811965, MIR4733HG, NF1Neurofibromatosis, type 1Pathogenic
(Jan 3, 2017)
criteria provided, single submitter
21.
GRCh37:
Chr17:29421945-29422387
GRCh38:
Chr17:31094927-31095369
LOC111811965, MIR4733HG, NF1Neurofibromatosis, type 1Uncertain significance
(Jan 10, 2017)
criteria provided, single submitter
22.
GRCh37:
Chr17:29421945-29704695
GRCh38:
Chr17:31094927-31377677
Neurofibromatosis, type 1Pathogenic
(Nov 27, 2019)
criteria provided, single submitter
23.
GRCh37:
Chr17:29421965
GRCh38:
Chr17:31094947
LOC111811965, MIR4733HG, NF1Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, familial spinal, Neurofibromatosis-Noonan syndrome,
Neurofibromatosis, type 1
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
24.
GRCh37:
Chr17:29422006
GRCh38:
Chr17:31094988
LOC111811965, MIR4733HG, NF1Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal, Café-au-lait macules with pulmonary stenosis,
Neurofibromatosis, type 1
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
25.
GRCh37:
Chr17:29422039-29422055
GRCh38:
Chr17:31095021-31095037
LOC111811965, MIR4733HG, NF1Neurofibromatosis, type 1Uncertain significance
(Aug 27, 2021)
criteria provided, single submitter
26.
GRCh37:
Chr17:29422055
GRCh38:
Chr17:31095037
LOC111811965, MIR4733HG, NF1Neurofibromatosis, type 1Uncertain significance
(Dec 16, 2021)
criteria provided, single submitter
27.
GRCh37:
Chr17:29422055
GRCh38:
Chr17:31095037
LOC111811965, MIR4733HG, NF1Neurofibromatosis, type 1Uncertain significance
(Sep 29, 2022)
criteria provided, single submitter
28.
GRCh37:
Chr17:29422056
GRCh38:
Chr17:31095038
LOC111811965, MIR4733HG, NF1Neurofibromatosis, type 1Pathogenic
(Jun 27, 2022)
criteria provided, single submitter
29.
GRCh37:
Chr17:29422056
GRCh38:
Chr17:31095038
LOC111811965, MIR4733HG, NF1not provided, Neurofibromatosis, type 1Conflicting interpretations of pathogenicity
(Oct 17, 2022)
criteria provided, conflicting interpretations
30.
GRCh37:
Chr17:29422063
GRCh38:
Chr17:31095045
LOC111811965, MIR4733HG, NF1Neurofibromatosis, familial spinal, Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis,
Neurofibromatosis, type 1
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
31.
GRCh37:
Chr17:29422076-29422077
GRCh38:
Chr17:31095058-31095059
LOC111811965, MIR4733HG, NF1Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal, Café-au-lait macules with pulmonary stenosis,
Neurofibromatosis, type 1
Uncertain significance
(Jun 14, 2016)
criteria provided, single submitter
32.
GRCh37:
Chr17:29422076-29422077
GRCh38:
Chr17:31095058-31095059
MIR4733HG, LOC111811965, NF1Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal, Café-au-lait macules with pulmonary stenosis,
Neurofibromatosis, type 1
Uncertain significance
(Jun 14, 2016)
criteria provided, single submitter
33.
GRCh37:
Chr17:29422077
GRCh38:
Chr17:31095059
LOC111811965, MIR4733HG, NF1Neurofibromatosis, familial spinal, Neurofibromatosis-Noonan syndrome, Neurofibromatosis, type 1,
Café-au-lait macules with pulmonary stenosis
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
34.
GRCh37:
Chr17:29422082-29422083
GRCh38:
Chr17:31095064-31095065
MIR4733HG, LOC111811965, NF1Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal, Café-au-lait macules with pulmonary stenosis,
Neurofibromatosis, type 1
Uncertain significance
(Jun 14, 2016)
criteria provided, single submitter
35.
GRCh37:
Chr17:29422087-29422088
GRCh38:
Chr17:31095069-31095070
LOC111811965, MIR4733HG, NF1Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal, Café-au-lait macules with pulmonary stenosis,
Neurofibromatosis, type 1
Uncertain significance
(Jun 14, 2016)
criteria provided, single submitter
36.
GRCh37:
Chr17:29422091
GRCh38:
Chr17:31095073
MIR4733HG, LOC111811965, NF1Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal, Café-au-lait macules with pulmonary stenosis,
Neurofibromatosis, type 1
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
37.
GRCh37:
Chr17:29422099
GRCh38:
Chr17:31095081
LOC111811965, MIR4733HG, NF1Neurofibromatosis, familial spinal, Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis,
Neurofibromatosis, type 1
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
38.
GRCh37:
Chr17:29422119
GRCh38:
Chr17:31095101
MIR4733HG, LOC111811965, NF1Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal, Café-au-lait macules with pulmonary stenosis,
Neurofibromatosis, type 1
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
39.
GRCh37:
Chr17:29422155
GRCh38:
Chr17:31095137
LOC111811965, MIR4733HG, NF1Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal, Café-au-lait macules with pulmonary stenosis,
Neurofibromatosis, type 1
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
40.
GRCh37:
Chr17:29422162
GRCh38:
Chr17:31095144
LOC111811965, MIR4733HG, NF1Neurofibromatosis, familial spinal, Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis,
Neurofibromatosis, type 1
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
41.
GRCh37:
Chr17:29422180
GRCh38:
Chr17:31095162
MIR4733HG, LOC111811965, NF1Neurofibromatosis-Noonan syndrome, Juvenile myelomonocytic leukemia, Neurofibromatosis, type 1,
Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, familial spinal,
Neurofibromatosis, familial spinal, Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, type 1
Uncertain significance
(Oct 27, 2021)
criteria provided, multiple submitters, no conflicts
42.
GRCh37:
Chr17:29422213
GRCh38:
Chr17:31095195
LOC111811965, MIR4733HG, NF1Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal, Café-au-lait macules with pulmonary stenosis,
Neurofibromatosis, type 1
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
43.
GRCh37:
Chr17:29422244
GRCh38:
Chr17:31095226
MIR4733HG, LOC111811965, NF1Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal, Café-au-lait macules with pulmonary stenosis,
Neurofibromatosis, type 1
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
44.
GRCh37:
Chr17:29422255
GRCh38:
Chr17:31095237
LOC111811965, MIR4733HG, NF1Neurofibromatosis-Noonan syndrome, Neurofibromatosis, familial spinal, Café-au-lait macules with pulmonary stenosis,
Neurofibromatosis, type 1
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
45.
GRCh37:
Chr17:29422277
GRCh38:
Chr17:31095259
LOC111811965, MIR4733HG, NF1Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, familial spinal,
Neurofibromatosis, type 1
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
46.
GRCh37:
Chr17:29422278-29701241
GRCh38:
Chr17:31095260-31374223
Neurofibromatosis, type 1Pathogenic
(Feb 6, 2018)
criteria provided, single submitter
47.
GRCh37:
Chr17:29422306
GRCh38:
Chr17:31095288
LOC111811965, MIR4733HG, NF1not specified, not provided, Café-au-lait macules with pulmonary stenosis,
Neurofibromatosis, type 1, Neurofibromatosis, familial spinal, Neurofibromatosis-Noonan syndrome
Benign/Likely benign
(Oct 1, 2023)
criteria provided, multiple submitters, no conflicts
48.
GRCh37:
Chr17:29422310
GRCh38:
Chr17:31095292
LOC111811965, MIR4733HG, NF1Hereditary cancer-predisposing syndromeLikely benign
(Oct 27, 2020)
criteria provided, single submitter
49.
GRCh37:
Chr17:29422318-29422397
GRCh38:
Chr17:31095300-31095379
LOC111811965, MIR4733HG, NF1Neurofibromatosis, type 1Pathogenic
(Dec 18, 2018)
criteria provided, single submitter
50.
GRCh37:
Chr17:29422318-29422397
GRCh38:
Chr17:31095300-31095379
LOC111811965, MIR4733HG, NF1Neurofibromatosis, type 1Uncertain significance
(Jun 13, 2019)
criteria provided, single submitter
51.
GRCh37:
Chr17:29422318-29701183
GRCh38:
Chr17:31095300-31374165
Neurofibromatosis, type 1Uncertain significance
(Jul 9, 2019)
criteria provided, single submitter
52.
GRCh37:
Chr17:29422318-29701183
GRCh38:
Chr17:31095300-31374165
Neurofibromatosis, type 1Pathogenic
(Jul 16, 2019)
criteria provided, single submitter
53.
GRCh37:
Chr17:29422320
GRCh38:
Chr17:31095302
LOC111811965, MIR4733HG, NF1Neurofibromatosis, type 1Uncertain significance
(Aug 26, 2015)
criteria provided, single submitter
54.
GRCh37:
Chr17:29422322-29701179
GRCh38:
Chr17:31095304-31374161
Neurofibromatosis, type 1Pathogenic
(Nov 6, 2019)
criteria provided, single submitter
55.
GRCh37:
Chr17:29422322-29701179
GRCh38:
Chr17:31095304-31374161
Neurofibromatosis, type 1Uncertain significance
(Sep 19, 2017)
criteria provided, single submitter
56.
GRCh37:
Chr17:29422322-29483150
GRCh38:
Chr17:31095304-31156132
LOC108281169, LOC111811965, MIR4733HG, NF1Neurofibromatosis, type 1Pathogenic
(Oct 10, 2017)
criteria provided, single submitter
57.
GRCh37:
Chr17:29422324
GRCh38:
Chr17:31095306
LOC111811965, MIR4733HG, NF1Hereditary cancer-predisposing syndrome, Cardiovascular phenotypeUncertain significance
(Mar 10, 2021)
criteria provided, single submitter
58.
GRCh37:
Chr17:29422325-29422329
GRCh38:
Chr17:31095307-31095311
LOC111811965, MIR4733HG, NF1M1fsCardiovascular phenotype, Hereditary cancer-predisposing syndromePathogenic
(Jun 29, 2022)
criteria provided, single submitter
59.
GRCh37:
Chr17:29422326
GRCh38:
Chr17:31095308
MIR4733HG, NF1, LOC111811965Cardiovascular phenotype, Hereditary cancer-predisposing syndromeUncertain significance
(Oct 8, 2018)
criteria provided, single submitter
60.
GRCh37:
Chr17:29422326
GRCh38:
Chr17:31095308
LOC111811965, MIR4733HG, NF1Hereditary cancer-predisposing syndromeUncertain significance
(May 8, 2015)
criteria provided, single submitter
61.
GRCh37:
Chr17:29422328
GRCh38:
Chr17:31095310
MIR4733HG, NF1, LOC111811965M1LNeurofibromatosis, type 1, Cardiovascular phenotype, Hereditary cancer-predisposing syndrome
Pathogenic
(Oct 21, 2021)
criteria provided, multiple submitters, no conflicts
62.
GRCh37:
Chr17:29422328
GRCh38:
Chr17:31095310
LOC111811965, MIR4733HG, NF1M1LNeurofibromatosis, type 1Likely pathogeniccriteria provided, single submitter
63.
GRCh37:
Chr17:29422328
GRCh38:
Chr17:31095310
LOC111811965, MIR4733HG, NF1M1VNeurofibromatosis, type 1, Hereditary cancer-predisposing syndrome, Cardiovascular phenotype,
not provided
Pathogenic
(Oct 28, 2022)
criteria provided, multiple submitters, no conflicts
64.
GRCh37:
Chr17:29422329
GRCh38:
Chr17:31095311
LOC111811965, MIR4733HG, NF1M1KNeurofibromatosis, type 1, Cardiovascular phenotype, Hereditary cancer-predisposing syndrome,
not provided
Pathogenic/Likely pathogenic
(Mar 15, 2022)
criteria provided, multiple submitters, no conflicts
65.
GRCh37:
Chr17:29422329
GRCh38:
Chr17:31095311
MIR4733HG, LOC111811965, NF1M1RCardiovascular phenotype, Hereditary cancer-predisposing syndrome, not provided,
Neurofibromatosis, type 1
Pathogenic
(Sep 6, 2022)
criteria provided, multiple submitters, no conflicts
66.
GRCh37:
Chr17:29422329
GRCh38:
Chr17:31095311
LOC111811965, MIR4733HG, NF1M1Tnot provided, Neurofibromatosis, type 1, Hereditary cancer-predisposing syndrome,
Cardiovascular phenotype
Pathogenic
(Oct 12, 2022)
criteria provided, multiple submitters, no conflicts
67.
GRCh37:
Chr17:29422330
GRCh38:
Chr17:31095312
MIR4733HG, LOC111811965, NF1M1IHereditary cancer-predisposing syndrome, Cardiovascular phenotypePathogenic
(Feb 14, 2019)
criteria provided, single submitter
68.
GRCh37:
Chr17:29422330
GRCh38:
Chr17:31095312
LOC111811965, MIR4733HG, NF1M1ICardiovascular phenotype, Hereditary cancer-predisposing syndrome, Neurofibromatosis, type 1
Pathogenic
(Feb 10, 2022)
criteria provided, multiple submitters, no conflicts
69.
GRCh37:
Chr17:29422331
GRCh38:
Chr17:31095313
LOC111811965, MIR4733HG, NF1A2SCardiovascular phenotype, Hereditary cancer-predisposing syndrome, Neurofibromatosis, type 1
Uncertain significance
(Feb 22, 2022)
criteria provided, multiple submitters, no conflicts
70.
GRCh37:
Chr17:29422331-29422332
GRCh38:
Chr17:31095313-31095314
LOC111811965, MIR4733HG, NF1A2Fnot provided, Hereditary cancer-predisposing syndrome, Cardiovascular phenotype,
Neurofibromatosis, type 1
Uncertain significance
(Aug 7, 2023)
criteria provided, multiple submitters, no conflicts
71.
GRCh37:
Chr17:29422332
GRCh38:
Chr17:31095314
LOC111811965, MIR4733HG, NF1A2DNeurofibromatosis, type 1, not providedUncertain significance
(Oct 28, 2022)
criteria provided, multiple submitters, no conflicts
72.
GRCh37:
Chr17:29422332
GRCh38:
Chr17:31095314
LOC111811965, MIR4733HG, NF1A3fsNeurofibromatosis, type 1Pathogenic
(Oct 11, 2020)
criteria provided, single submitter
73.
GRCh37:
Chr17:29422332
GRCh38:
Chr17:31095314
LOC111811965, MIR4733HG, NF1A2VHereditary cancer-predisposing syndromeUncertain significance
(Jan 12, 2016)
criteria provided, single submitter
74.
GRCh37:
Chr17:29422333
GRCh38:
Chr17:31095315
MIR4733HG, LOC111811965, NF1Neurofibromatosis, type 1, Cardiovascular phenotype, Hereditary cancer-predisposing syndrome
Likely benign
(Sep 6, 2022)
criteria provided, multiple submitters, no conflicts
75.
GRCh37:
Chr17:29422333
GRCh38:
Chr17:31095315
LOC111811965, MIR4733HG, NF1Hereditary cancer-predisposing syndrome, Neurofibromatosis, type 1Likely benign
(Mar 15, 2022)
criteria provided, multiple submitters, no conflicts
76.
GRCh37:
Chr17:29422334
GRCh38:
Chr17:31095316
LOC111811965, MIR4733HG, NF1A3TNeurofibromatosis, type 1, Hereditary cancer-predisposing syndrome, Cardiovascular phenotype
Uncertain significance
(Feb 18, 2022)
criteria provided, multiple submitters, no conflicts
77.
GRCh37:
Chr17:29422335
GRCh38:
Chr17:31095317
LOC111811965, MIR4733HG, NF1A3EHereditary cancer-predisposing syndrome, Cardiovascular phenotypeUncertain significance
(Oct 5, 2021)
criteria provided, single submitter
78.
GRCh37:
Chr17:29422335
GRCh38:
Chr17:31095317
LOC111811965, MIR4733HG, NF1A3GNeurofibromatosis, type 1Uncertain significance
(Sep 1, 2021)
criteria provided, single submitter
79.
GRCh37:
Chr17:29422335
GRCh38:
Chr17:31095317
LOC111811965, MIR4733HG, NF1A3VCardiovascular phenotype, Hereditary cancer-predisposing syndrome, Neurofibromatosis, type 1
Uncertain significance
(Dec 29, 2021)
criteria provided, multiple submitters, no conflicts
80.
GRCh37:
Chr17:29422336
GRCh38:
Chr17:31095318
LOC111811965, MIR4733HG, NF1Cardiovascular phenotype, Hereditary cancer-predisposing syndromeLikely benign
(Dec 12, 2022)
criteria provided, single submitter
81.
GRCh37:
Chr17:29422336
GRCh38:
Chr17:31095318
LOC111811965, MIR4733HG, NF1Neurofibromatosis, type 1, Hereditary cancer-predisposing syndrome, Cardiovascular phenotype
Likely benign
(Apr 30, 2021)
criteria provided, multiple submitters, no conflicts
82.
GRCh37:
Chr17:29422336
GRCh38:
Chr17:31095318
LOC111811965, MIR4733HG, NF1H4fsnot provided, Neurofibromatosis, type 1Pathogenic
(Sep 17, 2023)
criteria provided, multiple submitters, no conflicts
83.
GRCh37:
Chr17:29422337
GRCh38:
Chr17:31095319
LOC111811965, MIR4733HG, NF1H4fsNeurofibromatosis, type 1Pathogenic
(Jan 15, 2022)
criteria provided, single submitter
84.
GRCh37:
Chr17:29422337
GRCh38:
Chr17:31095319
LOC111811965, MIR4733HG, NF1H4YNeurofibromatosis, type 1Uncertain significance
(Sep 29, 2021)
criteria provided, single submitter
85.
GRCh37:
Chr17:29422337
GRCh38:
Chr17:31095319
LOC111811965, MIR4733HG, NF1H4NNeurofibromatosis, type 1Uncertain significance
(Aug 20, 2021)
criteria provided, single submitter
86.
GRCh37:
Chr17:29422339
GRCh38:
Chr17:31095321
LOC111811965, MIR4733HG, NF1Hereditary cancer-predisposing syndrome, Cardiovascular phenotypeLikely benign
(Mar 8, 2021)
criteria provided, single submitter
87.
GRCh37:
Chr17:29422340
GRCh38:
Chr17:31095322
LOC111811965, MIR4733HG, NF1Hereditary cancer-predisposing syndrome, Cardiovascular phenotypeLikely benign
(Nov 4, 2021)
criteria provided, single submitter
88.
GRCh37:
Chr17:29422340
GRCh38:
Chr17:31095322
LOC111811965, MIR4733HG, NF1R5GCardiovascular phenotype, Hereditary cancer-predisposing syndrome, Neurofibromatosis, type 1
Uncertain significance
(Aug 30, 2021)
criteria provided, multiple submitters, no conflicts
89.
GRCh37:
Chr17:29422340
GRCh38:
Chr17:31095322
LOC111811965, MIR4733HG, NF1R5WCardiovascular phenotype, Hereditary cancer-predisposing syndromeUncertain significance
(Sep 4, 2019)
criteria provided, single submitter
90.
GRCh37:
Chr17:29422341
GRCh38:
Chr17:31095323
LOC111811965, MIR4733HG, NF1R5fsNeurofibromatosis, type 1Pathogenic
(Jan 15, 2020)
criteria provided, single submitter
91.
GRCh37:
Chr17:29422342
GRCh38:
Chr17:31095324
LOC111811965, MIR4733HG, NF1Neurofibromatosis, type 1Likely benign
(Mar 29, 2022)
criteria provided, single submitter
92.
GRCh37:
Chr17:29422342
GRCh38:
Chr17:31095324
LOC111811965, MIR4733HG, NF1R5SJuvenile myelomonocytic leukemia, Neurofibromatosis, familial spinal, Neurofibromatosis-Noonan syndrome,
Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, type 1, Neurofibromatosis, type 1
Uncertain significance
(Apr 12, 2022)
criteria provided, multiple submitters, no conflicts
93.
GRCh37:
Chr17:29422343
GRCh38:
Chr17:31095325
LOC111811965, MIR4733HG, NF1P6Snot providedUncertain significance
(Apr 18, 2018)
criteria provided, single submitter
94.
GRCh37:
Chr17:29422344
GRCh38:
Chr17:31095326
LOC111811965, MIR4733HG, NF1P6QCardiovascular phenotype, Hereditary cancer-predisposing syndromeUncertain significance
(Feb 19, 2020)
criteria provided, single submitter
95.
GRCh37:
Chr17:29422344
GRCh38:
Chr17:31095326
LOC111811965, MIR4733HG, NF1P6RNeurofibromatosis, type 1, Cardiovascular phenotype, Hereditary cancer-predisposing syndrome,
not provided
Uncertain significance
(Jul 11, 2022)
criteria provided, multiple submitters, no conflicts
96.
GRCh37:
Chr17:29422344
GRCh38:
Chr17:31095326
LOC111811965, MIR4733HG, NF1P6LHereditary cancer-predisposing syndrome, Cardiovascular phenotype, Juvenile myelomonocytic leukemia,
Neurofibromatosis, type 1, Neurofibromatosis, familial spinal, Neurofibromatosis-Noonan syndrome,
Café-au-lait macules with pulmonary stenosis, Neurofibromatosis, type 1
Uncertain significance
(Oct 5, 2022)
criteria provided, multiple submitters, no conflicts
97.
GRCh37:
Chr17:29422346
GRCh38:
Chr17:31095328
LOC111811965, MIR4733HG, NF1V7MNeurofibromatosis, type 1Uncertain significance
(Aug 28, 2021)
criteria provided, single submitter
98.
GRCh37:
Chr17:29422347-29422350
GRCh38:
Chr17:31095329-31095332
LOC111811965, MIR4733HG, NF1V7fsNeurofibromatosis, type 1Pathogenic
(Feb 16, 2021)
criteria provided, single submitter
99.
GRCh37:
Chr17:29422349-29422350
GRCh38:
Chr17:31095331-31095332
LOC111811965, MIR4733HG, NF1E8fsNeurofibromatosis, type 1Pathogenic
(Aug 16, 2021)
criteria provided, single submitter
100.
GRCh37:
Chr17:29422353-29422359
GRCh38:
Chr17:31095335-31095341
LOC111811965, MIR4733HG, NF1V10fsHereditary cancer-predisposing syndrome, Cardiovascular phenotypePathogenic
(Aug 20, 2020)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination